AB
BDSI

Amalgamated Bank’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Amalgamated Bank’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,443
Closed -$51K – 3075
2021
Q4 		$51K Sell
16,443
-453
-3% -$1.52K ﹤0.01% 2110
2021
Q3 		$61K Sell
16,896
-692
-4% -$2.61K ﹤0.01% 2118
2021
Q2 		$63K Buy
17,588
+3,565
+25% +$12.6K ﹤0.01% 2150
2021
Q1 		$55K Hold
14,023
– – ﹤0.01% 1576
2020
Q4 		$59K Buy
14,023
+64
+0.5% +$247 ﹤0.01% 1556
2020
Q3 		$52K Sell
13,959
-177
-1% -$753 ﹤0.01% 1457
2020
Q2 		$62K Sell
14,136
-652
-4% -$2.93K ﹤0.01% 1440
2020
Q1 		$56K Sell
14,788
-573
-4% -$2.82K ﹤0.01% 1557
2019
Q4 		$97K Buy
15,361
+916
+6% +$5.38K ﹤0.01% 1739
2019
Q3 		$61K Sell
14,445
-92
-0.6% -$393 ﹤0.01% 1691
2019
Q2 		$68K Buy
+14,537
New +$67.7K ﹤0.01% 1727

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Amalgamated Bank's BDSI Position: Q1 2022 in Review

Amalgamated Bank sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 16,443 shares — an estimated $51K sold.

Amalgamated Bank first reported a position in BDSI in Q2 2019 and held it in 11 quarters. The position peaked at $97K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Amalgamated Bank reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Amalgamated Bank sold 16,443 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $51K.
  • Amalgamated Bank first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 11 quarters.
  • Amalgamated Bank's BioDelivery Sciences International, Inc. position peaked at $97K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Amalgamated Bank's 13F filing for Q1 2022, filed 30 Jun 2022.